120 related articles for article (PubMed ID: 8414230)
1. Atovaquone: a new oral treatment for pneumocystis.
Nurse Pract; 1993 Sep; 18(9):22. PubMed ID: 8414230
[No Abstract] [Full Text] [Related]
2. Atovaquone to be marketed as oral therapy for Pneumocystis carinii pneumonia.
Clin Pharm; 1993 Mar; 12(3):175-6. PubMed ID: 8491073
[No Abstract] [Full Text] [Related]
3. Atovaquone (Mepron) suspension approved by FDA. Food and Drug Administration.
Cotton D
AIDS Clin Care; 1995 Jul; 7(7):62. PubMed ID: 11362554
[TBL] [Abstract][Full Text] [Related]
4. Atovaquone for Pneumocystis carinii pneumonia.
Med Lett Drugs Ther; 1993 Apr; 35(893):28-9. PubMed ID: 8450807
[No Abstract] [Full Text] [Related]
5. Atovaquone: a new antipneumocystis agent.
Artymowicz RJ; James VE
Clin Pharm; 1993 Aug; 12(8):563-70. PubMed ID: 8222520
[TBL] [Abstract][Full Text] [Related]
6. New AIDS drug available.
AORN J; 1992 Feb; 55(2):514. PubMed ID: 1536543
[No Abstract] [Full Text] [Related]
7. Treatment IND protocol announced for Pneumocystis carinii pneumonia.
Clin Pharm; 1992 Feb; 11(2):99, 103. PubMed ID: 1551304
[No Abstract] [Full Text] [Related]
8. Mepron for AIDS-related pneumonia.
Am Pharm; 1993 Mar; NS33(3):14-5. PubMed ID: 8475842
[No Abstract] [Full Text] [Related]
9. AIDS-related treatment receives IND status.
J Am Osteopath Assoc; 1992 Jan; 92(1):46. PubMed ID: 1559856
[No Abstract] [Full Text] [Related]
10. Pneumocystis carinii pneumonia treatment in people infected with HIV.
Bellamy R
Clin Evid; 2004 Jun; (11):935-50. PubMed ID: 15652046
[No Abstract] [Full Text] [Related]
11. Atovaquone as prophylaxis for Pneumocystis carinii.
Vilar FJ; McKendrick MW; Nash C
Int J STD AIDS; 1996 Jul; 7(4):302. PubMed ID: 8876368
[No Abstract] [Full Text] [Related]
12. [Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
Pastor C; Lumbreras C; Lizasoain M
Med Clin (Barc); 1994 Oct; 103(12):473-6. PubMed ID: 7996899
[No Abstract] [Full Text] [Related]
13. Atovaquone for Pneumocystis carinii pneumonia.
Stoeckle M; Tennenberg A
Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825772
[No Abstract] [Full Text] [Related]
14. Atovaquone for Pneumocystis carinii pneumonia.
Lederman MM; van der Horst C
Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825771
[No Abstract] [Full Text] [Related]
15. Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia.
White A; LaFon S; Rogers M; Andrews E; Brown N
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):280-5. PubMed ID: 7788426
[TBL] [Abstract][Full Text] [Related]
16. [Therapy and prevention of pneumocystis carinii pneumonia].
Goebel FD; Bogner JR
Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
[No Abstract] [Full Text] [Related]
17. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
Hughes WT
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):247-52. PubMed ID: 7859136
[TBL] [Abstract][Full Text] [Related]
18. Atovaquone.
Ungvarski P
J Assoc Nurses AIDS Care; 1993; 4(2):60-2. PubMed ID: 8369502
[No Abstract] [Full Text] [Related]
19. A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia.
Hughes WT
Ann Intern Med; 1992 Jun; 116(11):953-4. PubMed ID: 1580456
[No Abstract] [Full Text] [Related]
20. Criteria for use of atovaquone oral suspension in adult inpatients and outpatients.
Goodwin SD; Fish DN
Am J Health Syst Pharm; 1995 Nov; 52(21):2460-2. PubMed ID: 8564614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
